Identification of cross-stage, cross-species malaria CD8+ T cell antigens.

Saved in:
Bibliographic Details
Title: Identification of cross-stage, cross-species malaria CD8+ T cell antigens.
Authors: Barbosa CRR; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil., de Lacerda LB; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Bettencourt PJG; Jenner Institute, University of Oxford, Oxford, UK.; Center for Interdisciplinary Research in Health, Faculty of Medicine, Universidade Católica Portuguesa, Lisbon, Portugal., Morrow D; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA., Pereira DB; Centro de Pesquisas em Medicina Tropical de Rondônia, Porto Velho, Brazil., Aleshnick M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA., Mitchell JL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA., Poulton NC; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Gomes C; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.; Departmaneto de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Cordeiro LPB; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Doumbia K; Parasites and Microbes Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Ntalla C; Max Planck Institute for Infection Biology, Berlin, Germany., Arama C; Parasites and Microbes Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Zhao Z; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA., Maia GC; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.; Departmaneto de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Almeida GG; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Schrimpf MR; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Hart TF; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA., Haumpy D; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA., Medeiros-Rodrigues BC; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil., Costa CM; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil., Nicastri A; Jenner Institute, University of Oxford, Oxford, UK.; Chester Beatty Laboratories, Institute of Cancer Research, London, UK., Gilbride RM; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA., Schell JB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA., Kirtley P; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA., Antonelli LRV; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil., Gaiha GD; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA.; Program in Health Sciences and Technology, Harvard Medical School and Massachusetts Institute of Technology, Cambridge, MA, USA.; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Hansen SG; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA., Lieberman J; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Gazzinelli RT; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.; Departmaneto de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Niangaly M; Parasites and Microbes Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.; Max Planck Institute for Infection Biology, Berlin, Germany., Woodford J; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; QIMR Berghofer, Brisbane, Queensland, Australia., Goldberg J; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Früh K; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA., Portugal S; Max Planck Institute for Infection Biology, Berlin, Germany., Duffy PE; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Ternette N; Jenner Institute, University of Oxford, Oxford, UK.; School of Life Sciences, University of Dundee, Dundee, UK., Wilder B; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA. wilderb@ohsu.edu., Hill AVS; Jenner Institute, University of Oxford, Oxford, UK. adrian.hill@ndm.ox.ac.uk., Junqueira C; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil. caroline.junqueira@irb.usi.ch.; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. caroline.junqueira@irb.usi.ch.; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland. caroline.junqueira@irb.usi.ch.
Source: Nature [Nature] 2026 Jul; Vol. 655 (8123), pp. 747-757. Date of Electronic Publication: 2026 Jul 01.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/s41586-026-10730-1